Data updated: Mar 10, 2026
FLONASE SENSIMIST ALLERGY RELIEF
FLUTICASONE FUROATE
Approved 2007-04-27
3
Indications
--
Phase 3 Trials
18
Years on Market
Details
- Status
- Over-the-counter
- First Approved
- 2007-04-27
- Routes
- NASAL
- Dosage Forms
- SPRAY, METERED
FLONASE SENSIMIST ALLERGY RELIEF Approval History
Loading approval history...
What FLONASE SENSIMIST ALLERGY RELIEF Treats
3 FDA approvalsOriginally approved for its first indication in 2007 . Covers 3 distinct patient populations.
- Other (3)
Other
(3 approvals)- • Approved indication (Apr 2007)
- • Approved indication (Aug 2012)
- • Approved indication (Aug 2016)Label
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
FLONASE SENSIMIST ALLERGY RELIEF FDA Label Details
ProFLONASE SENSIMIST ALLERGY RELIEF Patents & Exclusivity
Latest Patent: Oct 2028
Patents (3 active)
Source: FDA Orange Book
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.